- Advancement reflects continued execution of capital-efficient development strategy leveraging POZ Platform™ - ...
A new plastic surgery procedure called alloClae allows patients to receive fat transfers from cadavers. The donor-derived tissue "allows surgeons to add volume in a controlled and targeted way without ...
14h
Medincell to Present at the TD Cowen 46th Annual Healthcare Conference in Boston, March 2-4, 2026
Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing long-acting injectable treatments (the "Company"), today announced its participation ...
NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results